| Net loss | -457.99K |
| Depreciation and amortization | 1.66M |
| Deferred income taxes and investment tax credits | 1.11M |
| Change in cash surrender value of officer's life insurance | -12.69K |
| Share-based compensation | 264K |
| Decrease in assets | -5.7M |
| Increase (decrease) in liabilities | 601.61K |
| Net cash used in operating activities | -2.49M |
| Capital expenditures | -2.29M |
| Proceeds from sale of property, plant and equipment | 40.97K |
| Other | |
| Net cash used in investing activities | -2.25M |
| Dividends on common shares | -1.48M |
| Issuance of common shares | 141.1K |
| Excess tax benefit from share-based compensation | |
| Repayment of long-term debt | |
| Borrowings on bank line of credit | |
| Repayment of bank line of credit | |
| Net cash provided by financing activities | -1.6M |
| DECREASE IN CASH AND CASH EQUIVALENTS | -6.34M |
| CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | 18.61M |
| CASH AND CASH EQUIVALENTS, END OF PERIOD | 12.27M |